Suchergebnisse - "Salcedo, María-Teresa"

PubPharm (37)

1

An algorithm based on immunotherapy discontinuation and liver biopsy spares corticosteroids in two thirds of cases of severe checkpoint inhibitor-induced liver injury

enthalten in: Alimentary pharmacology & therapeutics | 2024

von Riveiro-Barciela, M. | Barreira-Díaz, A. | Salcedo, M. | +16

2

An algorithm based on immunotherapy discontinuation and liver biopsy spares corticosteroids in two thirds of cases of severe checkpoint inhibitor‐induced liver injury

enthalten in: Alimentary Pharmacology & Therapeutics | 2024

von Riveiro‐Barciela, M. | Barreira‐Díaz, A. | Salcedo, M. | +16

3

Artificial intelligence-based pathology as a biomarker of sensitivity to atezolizumab-bevacizumab in patients with hepatocellular carcinoma : a multicentre retrospective study

enthalten in: The Lancet. Oncology | 2023

von Zeng, Q. | Klein, C. | Caruso, S. | +119

4

Optimization of Statin-Loaded Delivery Nanoparticles for Treating Chronic Liver Diseases by Targeting Liver Sinusoidal Endothelial Cells

enthalten in: Pharmaceutics | 2023

von Gil, M. | Khouri, L. | Raurell, I. | +12

5

Retreatment With Immune Checkpoint Inhibitors After a Severe Immune-Related Hepatitis : Results From a Prospective Multicenter Study

enthalten in: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 2023

von Riveiro-Barciela, M. | Barreira-Díaz, A. | Callejo-Pérez, A. | +6

6

Liver steatosis induces portal hypertension regardless of fibrosis in patients with NAFLD : A proof of concept case report

enthalten in: JHEP reports : innovation in hepatology | 2023

von Rivera-Esteban, J. | Barberá, A. | Salcedo, M. | +3

7

ACE Score Identifies HBeAg-negative Inactive Carriers at a Single-point Evaluation, Regardless of HBV Genotype

enthalten in: Journal of clinical and translational hepatology | 2022

von Roade, L. | Riveiro-Barciela, M. | Palom, A. | +10

8

Ultra Deep Sequencing of Circulating Cell-Free DNA as a Potential Tool for Hepatocellular Carcinoma Management

enthalten in: Cancers | 2022

von Higuera, M. | Vargas-Accarino, E. | Torrens, M. | +12

9

A Nine-Strain Bacterial Consortium Improves Portal Hypertension and Insulin Signaling and Delays NAFLD Progression In Vivo

enthalten in: Biomedicines | 2022

von Pinheiro, I. | Barberá, A. | Raurell, I. | +10

10

Risk of infections in patients with NAFLD and Type 2 Diabetes under treatment with SGLT2 inhibitors and relationship with liver outcomes : A retrospective case-control study

enthalten in: Frontiers in endocrinology | 2022

von Bañares, J. | Manzano-Nuñez, R. | Prió, A. | +10